What do hospitals do for patient outcomes? 30 day mortality after heart attack Future of healthcare in Europe 13 May 2011.

Slides:



Advertisements
Similar presentations
Unstable angina and NSTEMI
Advertisements

Local improvement following national clinical audit workshops Auditing heart attacks Saving lives Dr Andrew Wragg Barts Health.
Social Factors Matter Class, Race and Gender in Health Outcomes.
CVD prevention & management: a new approach for primary care Rod Jackson School of Population Health University of Auckland New Zealand.
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
A Profile of Chronic Disease in Nevada Tracey Green, MD Nevada State Health Officer January Shaping a Healthy Nevada: Making a Difference in.
Grinols and Mustard Impact of a casino opening on crime rates Concern: casinos are not random – opened in struggling areas Data at county/year level –
Resection rate for patients with tissue confirmation of NSCLC ( :England) First seen in centre with thoracic surgery? Number With a tissue diagnosis.
Efficacy and safety of angiotensin receptor blockers: a meta-analysis of randomized trials Elgendy IY et al. Am J Hypertens. 2014; doi:10,1093/ajh/hpu209.
analysis from the SHIFT study
How is place of death for cancer patients changing and what affects it? UKACR Conference September 28 th 2004 Elizabeth Davies Karen Linklater Ruth Jack.
The Contribution of Mental Health Services to Tackling Health Inequalities Dr Alastair Cook Chair RCPsych in Scotland.
1 National trends in rates of death and hospital admissions related to acute myocardial infarction, heart failure and stroke, 1994–2004 CIHR Team Grant.
Professor Roger Boyle CBE National Director for Heart Disease and Stroke Department of Health PCI in the UK: Fit for service? A view from the Department.
CHARM-Alternative: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Alternative Purpose To determine whether the angiotensin.
CHARM-Preserved: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Preserved Purpose To determine whether the angiotensin.
Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose? Systolic.
BEAUTI f UL: morBidity-mortality EvAlUaTion of the I f inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction Purpose.
Cardiovascular mortality in Russia and other countries
Inequalities in coronary heart disease treatment Professor Azeem Majeed University College London.
Randomized, double-blind, multicenter, controlled trial.
© Nuffield Trust June 22, 2012 Adam Steventon: Evaluating the Whole System Demonstrator trial Authors: Adam Steventon, Martin Bardsley Nuffield Trust.
1 EFFECT STUDY 2 EFFECT STUDY  Set national cardiac care benchmarks for hospitals to work towards 
Optimizing Health Care Delivery and Outcomes Richard A. Hansen, PhD Gilliland Professor and Head Department of Health Outcomes Research and Policy.
Predicting risk of cardiovascular disease and the cost-effectiveness of interventions in Thailand Stephen Lim On Behalf of the Setting Priorities using.
S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial Main results Swedberg K, et al. Lancet. 2010;376(9744):
Intermediate outcome control in people with type 2 diabetes in the UK under comprehensive P4P Bruce Guthrie Alistair Emslie-Smith Andrew Morris.
Studying mortality trends: The IMPACT CHD Policy Model
Ho PM, et al. JAMA 2009;301: Baseline Characteristics of Patients Taking Clopidogrel After Hospital Discharge a Ho PM, et al. JAMA 2009;301:
Berlin Mare Ainsaar. Population influences everything Values Housing Media use Transportation Services Criminality Innovation Natural recources.
AIRE: Acute Infarction Ramipril Efficacy study Purpose To determine whether the ACE inhibitor ramipril reduces mortality in patients with evidence of heart.
THE URBAN INSTITUTE Examining Long-Term Care Episodes and Care History for Medicare Beneficiaries: A Longitudinal Analysis of Elderly Individuals with.
Characteristics of new users of statins in the period 1991–2004 in the PHARMO population F.J.A. Penning-van Beest, et al. European Heart Journal 2007;28:154–159.
Innovations in Management of Cardiovascular Disease for Global Health
Social Factors Matter Class, Race and Gender in Health Outcomes.
Slide Source: Lipids Online Slide Library ASTEROID Population at Baseline (n=507) Patients Completing (n=349) Patients Not Completing.
Term 4, 2006BIO656--Multilevel Models 1 PART 07 Evaluating Hospital Performance.
Polypill x Aspirin Project Groups 3 and 4
Measures of Disease Frequency
ELITE - II Study Design  60 yrs; NYHA II - IV; EF  40 % ACEI naive or  7 days in 3 months prior to entry Standard Rx ( ± Dig / Diuretics ), ß - blocker.
Shalev V, et al. Arch Intern Med 2009; 169:
World Population Social Studies 11. World Population The world population is the population of humans on the planet Earth In 2009, the United Nations.
Management of coronary heart disease in primary care Professor Azeem Majeed Primary Care Research Unit University College London.
Performance assessment A performance assessment framework is a collation of statistics across a district or within a hospital and is far removed from.
a) 4 billion b) 10 billion c) 6 billion a)2 b)5 c)7.
Mortality After Incident Cancer in People With and Without Type 2 Diabetes Featured Article: Craig J. Currie, Ph.D., Chris D. Poole, Ph.D., Sara Jenkins-Jones,
100 years of living science Implementing a Quality and Outcomes Framework in primary care: a UK perspective Dr Shamini Gnani November 2007, Mauritius.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Flow Diagram of the Trial Selection Process Jeffrey S. Berger et al, JAMA. 2006;295:
Variation in place of death from cancer: studies in South East England Elizabeth Davies, Peter Madden, Victoria Coupland, Karen Linklater, Henrik Møller.
Pharmacy in Public Health: Describing Populations Course, date, etc. info.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Presidential address: quality of cardiovascular.
Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial Infarction by Mikhail Kosiborod, Saif S. Rathore, Silvio E. Inzucchi,
Associate Professor, Honorary Consultant Cardiologist
Health …the sedimentation of society
An analysis of 22,672 patients from the CLARIFY registry
Instructional Objectives:
Hypertension November 2016
Flow of Individuals Through the Vitamin E and Vitamin C Components of the Physicians’ Health Study II Howard D. Sesso et al. JAMA 2008;300:
A “Scottish effect” for health?
Copyright © 2007 American Medical Association. All rights reserved.
Teaching Tool: Blood Pressure Classification
Baseline characteristics of patients
Date: Presenter: Ryan Chen
وضعیت موجود مرگ و میر و علل مرگ غیر مادری در افراد سال کارشناس اداره سلامت میانسالان معصومه آرشین چی همدان 27 و 28 تیرماه 1396.
Hypertension November 2016
Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.
Value Based Healthcare King’s Health Partners
Health profile used in workshops to help people make diabetes management decisions. Health profile used in workshops to help people make diabetes management.
Characteristics of 3415 patients admitted to hospital with
Presentation transcript:

What do hospitals do for patient outcomes? 30 day mortality after heart attack Future of healthcare in Europe 13 May 2011

Variation between hospitals in mortality Krumholz et al JAMA 2009 Target “outliers” ? Improve whole population and shift the mean ?

But wide variation remains Public, policy understanding of ‘wide’ variation needs metrics Consider ageing by 5 years A hospital which “ages patients by 5 years” (hazard ratio of 1.3) important for policy How common is such an effect?

Important hospital effects on death: common Hazard ratio (1=average across all hospitals) Probability density of hospitals Having a given effect on mortality UK Registry MINAP (Myocardial Ischaemia National Audit Project) n = 150,000 patients in 100 hospitals 21% of UK hospitals have this ‘5 year ageing’ effect

How well do we explain this variation? Hazard ratio (1=average across all hospitals) Probability density Case mix Patient treatments Hospital characteristics

Measured treatments explain little Crude Treatments + hospital characteristics aspirin, beta-blockers, ACE inhibitors, statins; % patients under cardiologist, angiography on site, volume Case mix Age, sex, admission heart rate, admission BP, smoking, diabetes, type of heart attack Hazard ratio for mortality (1=average across all hospitals)

Challenges What else are hospitals doing to influence outcome, which may be actionable? Need for electronic health record research Need for qualitative research What is the picture across Europe? International comparisons in disease prognosis (outcomes research) need to become a priority FP-7

“a fiftieth part of the whole die out of the Hospitals at London, and … 20 times that proportion die out of the Paris Hospitals…We Infer that either the Physicians and [Sur]geons of London are better than those of Paris, or that the Air of London is more wholesome” William Petty 1687 “Two essays in political arithmetick concerning the people, housing, hospitals etc. of London and Paris”